Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	March 31, 2024		December 31, 2023
Compensation, bonuses and related benefits	$	1,109	$	3,496
Research and development	4,728		4,895
Accrued severance, bonus, and retention (1)	68		2,476
Accrued offering costs in connection with pre-closing financing	—		3,334
Accrued transaction costs related to reverse merger	—		2,557
Other	919		737
Total accrued expenses and other current liabilities	$	6,824	$	17,495

(1) Includes accrued severance, bonus, and retention payments for current and former Neoleukin employees.